Department of General Surgery, Nanjing Drum Tower Clinical College of Xuzhou Medical University, Nanjing, Jiangsu, China.
Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Eur J Clin Nutr. 2024 Oct;78(10):880-886. doi: 10.1038/s41430-024-01469-x. Epub 2024 Jul 10.
It was reported that the cachexia index (CXI: ) was an essential index for predicting the prognosis of tumor patients. However, since for SMI needs to be measured by CT imaging methods and its calculation was inconvenient. Thus, we developed a modified cachexia index (mCXI: ). The purpose of this study was to evaluate the association between mCXI and prognosis in patients with colorectal cancer.
An analysis of 215 patients with newly diagnosed colorectal cancer was carried out retrospectively. An optimal cut-off value of mCXI was established by the receiver operating characteristic (ROC) curves for predicting prognosis. Prognostic implications of mCXI were investigated using Kaplan-Meier curves and Cox regression analysis. A comparative assessment of the predictive capacity between mCXI and the CXI was performed using time-dependent receiver operating characteristic analysis.
Patients were classified into two groups based on the cut-off value of mCXI: the LOW mCXI group (n = 60) and the HIGH mCXI group (n = 155). The 3-year Overall survival (OS) (76.6% vs 96.7%, p < 0.01) and 3-year Recurrence-free survival (RFS) (68.3% vs 94.1%, p < 0.01) were significantly worse in the LOW mCXI group in contrast to that in the HIGH mCXI group. In Cox multivariate regression analysis, mCXI was an independent prognostic factor for OS (HR = 8.951, 95%CI: 3.105-25.807, <0.01). Moreover, compared with CXI (AUC = 0.723), mCXI (AUC = 0.801) has better predictive efficacy, indicating that mCXI is more suitable for prognostic assessment.
The mCXI significantly correlated with survival outcomes for colorectal cancer patients after radical surgery.
据报道,恶病质指数(CXI:)是预测肿瘤患者预后的重要指标。然而,由于 SMI 需要通过 CT 成像方法测量,其计算不方便。因此,我们开发了改良的恶病质指数(mCXI:)。本研究旨在评估 mCXI 与结直肠癌患者预后的相关性。
回顾性分析 215 例新诊断为结直肠癌的患者。通过受试者工作特征(ROC)曲线确定 mCXI 的最佳截断值,以预测预后。通过 Kaplan-Meier 曲线和 Cox 回归分析研究 mCXI 的预后意义。通过时间依赖性 ROC 分析比较 mCXI 和 CXI 的预测能力。
根据 mCXI 的截断值,患者被分为两组:低 mCXI 组(n=60)和高 mCXI 组(n=155)。与高 mCXI 组相比,低 mCXI 组的 3 年总生存率(OS)(76.6% vs 96.7%,p<0.01)和 3 年无复发生存率(RFS)(68.3% vs 94.1%,p<0.01)明显较差。在 Cox 多变量回归分析中,mCXI 是 OS 的独立预后因素(HR=8.951,95%CI:3.105-25.807,<0.01)。此外,与 CXI(AUC=0.723)相比,mCXI(AUC=0.801)具有更好的预测效果,表明 mCXI 更适合预后评估。
mCXI 与结直肠癌根治术后患者的生存结局显著相关。